EX-12.1 3 a2232929zex-12_1.htm EX-12.1

Exhibit 12.1

 

Idera Pharmaceuticals, Inc.

 

Calculation of Ratios of Earnings to Combined Fixed Charges and Preferred Stock Dividends

 

 

 

Six
Months
Ended
June 30,

 

For the Year Ended December 31,

 

(in thousands)

 

2017

 

2016

 

2015

 

2014

 

2013

 

2012

 

Earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss before income taxes

 

$

(36,528

)

$

(38,389

)

$

(48,555

)

$

(38,642

)

$

(18,226

)

$

(19,240

)

Add: fixed charges

 

429

 

728

 

676

 

590

 

534

 

532

 

Earnings as defined

 

$

(36,099

)

$

(37,661

)

$

(47,879

)

$

(38,052

)

$

(17,692

)

$

(18,708

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed Charges and Preferred Stock Dividends:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

29

 

80

 

105

 

27

 

—

 

—

 

Estimated interest component within rental expense (1)

 

400

 

648

 

571

 

563

 

534

 

532

 

Total fixed charges

 

429

 

728

 

676

 

590

 

534

 

532

 

Preferred stock dividends

 

—

 

1

 

1

 

519

 

1,115

 

710

 

Total fixed charges and preferred stock dividends

 

$

429

 

$

729

 

$

677

 

$

1,109

 

$

1,649

 

$

1,242

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratio of earnings to combined fixed charges and preferred stock dividends:

 

*

 

*

 

*

 

*

 

*

 

*

 

Deficiency

 

$

(36,528

)

$

(38,390

)

$

(48,556

)

$

(39,161

)

$

(19,341

)

$

(19,950

)

 

(1)         Interest component of rental expense is estimated to equal 1/3 of such expense, which is considered a reasonable approximation of the interest factor.

 

*           Earnings for the period indicated were inadequate to cover fixed charges and preferred stock dividends. The amount of the deficiency by which earnings did not cover fixed charges and preferred stock dividends is disclosed in the above table for each applicable period.